Skip to main content
Clinical Trials/NCT02383095
NCT02383095
Terminated
Not Applicable

Efficiency of Art-therapy in Psychotic Disorders

University Hospital, Strasbourg, France1 site in 1 country9 target enrollmentMay 27, 2015
ConditionsSchizophrenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
University Hospital, Strasbourg, France
Enrollment
9
Locations
1
Primary Endpoint
Change in Response times between baseline and after 16 therapy sessions
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

The main purpose of the protocol is to test the efficiency of art-therapy versus metacognitive rehabilitation on the visual perception disorders observed in patients with schizophrenia.

Registry
clinicaltrials.gov
Start Date
May 27, 2015
End Date
October 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • schizophrenia according to DSM IV

Exclusion Criteria

  • addiction problem
  • invalidating visual sensory problems
  • neurological history

Outcomes

Primary Outcomes

Change in Response times between baseline and after 16 therapy sessions

Time Frame: Baseline and after 16 therapy sessions (up to 6 months)

Secondary Outcomes

  • Change in Clinical scales (SAPS and SANS) between baseline and after 16 therapy sessions(Baseline and after 16 therapy sessions (up to 6 months))
  • Change in errors in visual organization tasks between baseline and after 16 therapy sessions(aseline and after 16 therapy sessions (up to 6 months))
  • Change in esthetic perception between baseline and after 16 therapy sessions(Baseline and after 16 therapy sessions (up to 6 months))

Study Sites (1)

Loading locations...

Similar Trials